Grant: Strategic Projects - Group
University of Toronto
$180,500.00
Quantum dot biosensors; microfluidics-based manufacturing of a diagnostic tool
FY 2010-11
Summary
Quantum Dots (QDs) represent one newer form of technology that is now being exploited for the detection and tracking of dynamic cellular events in living systems. The goal of this research is to develop a manufacturing process that will offer a new tool for nucleic acid diagnostics at the cellular and intracellular levels, to ultimately enable the early detection of disease and to monitor disease progression and therapeutic efficacy. Two technology platforms are required to achieve the manufacturing goal: 1. We will design and construct a microfluidic reactor and suitable surface chemistries to produce QD-biosensors. The reactor will be based on solid-phase synthetic modification of immobilized QDs. Biosensors will be based on oligonucleotides that are immobilized on QDs, with the transduction system operated in fluorescence resonance energy transfer mode. The biosensors will be self-contained, meaning that fluorescently labelled nucleic acid targets are not required. Small molecule and peptide tags will be co-immobilized with oligonucleotides onto the QDs as a vector to selectively deliver QD-biosensors to targeted cells. In collaboration with our industry partner GL Chemtec, we will develop synthetic methodologies and validate the quality of the products from the reactor. 2. We will design and construct a separate microfluidic tool for rapid assessment of the performance of QD-biosensors produced in the reactor. The microfluidic tool will allow for moderate throughput investigation of the interactions between QD-biosensors and individual living cells. This will allow evaluation of the performance of the functional materials, which will guide development and optimization of the design of the manufacturing process to improve performance of QD-biosensors.
Program
Strategic Projects - Group
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
381032-2009
Name nom
Krull, Ulrich
Department département
Chemical and Physical Sciences
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
180500
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1088
Committee name en
Strategic Projects Selection Panel - Manufacturing - B
Committee name fr
Comité de sélection des projets stratégiques - Fabrication - B
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
2
Nb partie
3
Application title
Quantum dot biosensors; microfluidics-based manufacturing of a diagnostic tool
Keyword
NSERC
Application summary
Quantum Dots (QDs) represent one newer form of technology that is now being exploited for the detection and tracking of dynamic cellular events in living systems. The goal of this research is to develop a manufacturing process that will offer a new tool for nucleic acid diagnostics at the cellular and intracellular levels, to ultimately enable the early detection of disease and to monitor disease progression and therapeutic efficacy. Two technology platforms are required to achieve the manufacturing goal: 1. We will design and construct a microfluidic reactor and suitable surface chemistries to produce QD-biosensors. The reactor will be based on solid-phase synthetic modification of immobilized QDs. Biosensors will be based on oligonucleotides that are immobilized on QDs, with the transduction system operated in fluorescence resonance energy transfer mode. The biosensors will be self-contained, meaning that fluorescently labelled nucleic acid targets are not required. Small molecule and peptide tags will be co-immobilized with oligonucleotides onto the QDs as a vector to selectively deliver QD-biosensors to targeted cells. In collaboration with our industry partner GL Chemtec, we will develop synthetic methodologies and validate the quality of the products from the reactor. 2. We will design and construct a separate microfluidic tool for rapid assessment of the performance of QD-biosensors produced in the reactor. The microfluidic tool will allow for moderate throughput investigation of the interactions between QD-biosensors and individual living cells. This will allow evaluation of the performance of the functional materials, which will guide development and optimization of the design of the manufacturing process to improve performance of QD-biosensors.